Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA.
Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave. Ste 1600, Seattle, WA, 98101, USA.
Breast Cancer Res Treat. 2020 Jun;181(2):255-268. doi: 10.1007/s10549-020-05637-y. Epub 2020 Apr 17.
Women with personal history of breast cancer (PHBC) are currently recommended to receive annual mammography for surveillance of breast cancer recurrence or new primary. However, given issues in accuracy with mammography, there is a need for evolving evidence-based surveillance recommendations with supplemental imaging. In this systematic review, we compiled and compared existing studies that describe the test performance of surveillance breast MRI among women with PHBC.
We searched PubMed and EMBASE using MeSH terms for studies (2000-2019) that described the diagnostic characteristics of breast MRI in women with PHBC. Search results were reviewed and included based on PICOTS criteria; quality of included articles was assessed using QUADAS-2. Meta-analysis of single proportions was conducted for diagnostic characteristics of breast MRI, including tests of heterogeneity.
Our review included 11 articles in which unique cohorts were studied, comprised of a total of 8338 women with PHBC and 12,335 breast MRI done for the purpose of surveillance. We predict intervals (PI) for cancer detection rate per 1000 examinations (PI 9-15; I = 10%), recall rate (PI 5-31%; I = 97%), sensitivity (PI 58-95%; I = 47%), specificity (PI 76-97%; I = 97%), and PPV3 (PI 16-40%; I = 44%).
Studies addressing performance of breast MRI are variable and limited in population-based studies. The summary of evidence to date is insufficient to recommend for or against use of breast MRI for surveillance among women with PHBC.
有乳腺癌个人病史(PHBC)的女性目前建议每年进行乳房 X 线摄影术进行乳腺癌复发或新原发性肿瘤的监测。然而,鉴于乳房 X 线摄影术的准确性问题,需要制定基于循证的监测建议,并补充影像学检查。在这项系统评价中,我们汇集并比较了现有的研究,这些研究描述了 PHBC 女性中监测性乳腺 MRI 的检测性能。
我们使用 MeSH 术语在 PubMed 和 EMBASE 中搜索了描述 PHBC 女性乳腺 MRI 诊断特征的研究(2000-2019 年)。根据 PICOTS 标准审查和纳入研究结果;使用 QUADAS-2 评估纳入文章的质量。对乳腺 MRI 的诊断特征进行了单项比例的荟萃分析,包括异质性检验。
我们的综述包括 11 篇文章,其中研究了独特的队列,共包括 8338 名 PHBC 女性和 12335 例为监测目的而进行的乳腺 MRI。我们预测了每 1000 次检查的癌症检出率(PI 9-15;I=10%)、召回率(PI 5-31%;I=97%)、敏感性(PI 58-95%;I=47%)、特异性(PI 76-97%;I=97%)和 PPV3(PI 16-40%;I=44%)的预测区间(PI)。
目前针对乳腺 MRI 性能的研究在人群基础研究中存在差异且有限。迄今为止的证据总结不足以推荐或反对 PHBC 女性使用乳腺 MRI 进行监测。